A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
Active, not recruiting · NCT06328673 · Registry updated 2025-12-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors | Advanced Solid Tumor | Active, not recruiting | Phase 1 | 2025-12-24 | NCT06328673 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| D2M Biotherapeutics Inc. | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NEXT Oncology | San Antonio | United States | 1 |
| The Cancer Institute and Hospital, Chinese Academy of Medical Sciences(CAMS) | Beijing | China | 1 |